From: CircRNAs in anticancer drug resistance: recent advances and future potential
Drug | Cancer | CircRNAs | Mechanism | Role | Ref |
---|---|---|---|---|---|
Oxaliplatin | Colorectal Cancer | circ_032883 | Sponge miR-501-5p | Up | [126] |
circ_0338 | NA | Up | [127] | ||
circ_0005963 | MiR-122/PKM2 axis | Up | [128] | ||
Cisplatin | NSCLC | circ_0004350; circ_0092857 | Synergy effect with the parental EIF3a gene | Up | [131] |
circ_0076305 | MiR-296-5p/STAT3 axis | Up | [132] | ||
circPVT1 | MiR-145-5p/ABCC1 axis | Up | [135] | ||
circ_0001946 | Activating the NER signaling pathway to increased DNA repair ability | UP | [136] | ||
Osteosarcoma | circ_0004674 | NA | Up | [140] | |
circ_0001258 | MiR-744-3p/GSTM2 axis | Up | [141] | ||
circ_001569 | Activating Wnt/β-catenin signaling pathway | Up | [142] | ||
circPVT1 | Upregulate ABCB1 | Up | [143] | ||
circ_0081001 | NA | Up | [145] | ||
Hepatocellular Cancer | circRNA_101505 | MiR-103/NOR1 axis | Down | [151] | |
Gastric Cancer | circ_0081143 | MiR-646/CDK6 axis | Up | [154] | |
circAKT3 | MiR-198/ PIK3R1 axis | Up | [153] | ||
circFN1 | Sponging miR-182-5p | Up | [155] | ||
Ovarian Cancer | Cdr1as | MiR-1270/SCAI axis | Down | [156] | |
Bladder Cancer | circ_000285 | NA | Down | [157] | |
circFNTA | MiR-370-3p/FNTA axis | Up | [158] |